CasLoc logo
All Cases PTAB Litigations UPC Oppositions

NOVARTIS PHARMACEUTICALS CORPORATION v. BPI LABS LLC

2:15-cv-00950

Overview

Case Number 2:15-cv-00950
Filing Date 2015-02-05
Status Terminated
Termination Date 2016-05-31
Court District Court, D. New Jersey (njd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

NOVARTIS PHARMACEUTICALS CORPORATION Operating Company

Represented By

1 Attorneys Listed

Special Master

GARRETT E. BROWN NPE (Individual / Inventor)

Represented By

1 Attorneys Listed

GARRETT E. BROWN , JR.

JAMS

Tel: +1 (212) 607-2710

JAMS, 620 EIGHTH AVENUE

Counter Claimant

BPI LABS LLC Operating Company

Represented By

1 Attorneys Listed

Court & Judges

Court

District Court, D. New Jersey (njd)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

No Co-Pending Disputes Detected in Current Index

There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.

Patents Involved

No asserted patent numbers detected in initial docket filings yet.

Docket Entries

(13 total)
Pleading / Complaint

COMPLAINT against BPI LABS LLC ( Filing and Admin fee $ 400 receipt number 0312-6196413), filed by NOVARTIS PHARMACEUTICALS CORPORATION. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit A)(mfg) (Entered: 02/06/2015)

Entry #1 • 2015-02-05
1
Pleading / Complaint

COMPLAINT against BPI LABS LLC ( Filing and Admin fee $ 400 receipt number 0312-6196413), filed by NOVARTIS PHARMACEUTICALS CORPORATION. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit A)(mfg) (Entered: 02/06/2015)

Entry #1 • 2015-02-05
2
Pleading / Complaint

COMPLAINT against BPI LABS LLC ( Filing and Admin fee $ 400 receipt number 0312-6196413), filed by NOVARTIS PHARMACEUTICALS CORPORATION. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit A)(mfg) (Entered: 02/06/2015)

Entry #1 • 2015-02-05
2

Corporate Disclosure Statement by NOVARTIS PHARMACEUTICALS CORPORATION identifying NOVARTIS AG as Corporate Parent.. (mfg) (Entered: 02/06/2015)

Entry #3 • 2015-02-05
1
Pleading / Complaint

AO120 Patent/Trademark Form filed. (mfg) (Additional attachment(s) added on 2/6/2015: # 1 COMPLAINT, # 2 Exhibit A) (mfg, ). (Entered: 02/06/2015)

Entry #4 • 2015-02-05
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc